NFKB1 and diffuse large B-cell lymphoma: A study reported that IkB‐ζ expression seemed to be controlled through NF‐kB signaling in the vast majority of ABC DLBCL cases, as its expression was induced by mutants identified in patient samples that activated the NF‐kB pathway 42.